Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial
About the Authors
Giuseppe DerosaRussian Federation
Arrigo F.g. Cicero
Russian Federation
Angela D'angelo
Russian Federation
Elena Fogari
Russian Federation
Sibilla Salvadeo
Russian Federation
Alessia Gravina
Russian Federation
Ilaria Ferrari
Russian Federation
Raffaella Fassi
Russian Federation
Roberto Fogari
Russian Federation
Review
For citations:
, , , , , , , , Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial. Systemic Hypertension. 2009;(1):54-58.